Skip to main content
. 2021 Feb 15;7(2):e53. doi: 10.1192/bjo.2021.10

Table 1.

Characteristics of total patient cohort: sociodemographics, most recent SMI diagnosis, cluster, number and type of medications taken, and physical conditions

Characteristica n (%), n = 2971
Age Mean [s.d.] 47.4 [12.0]
Gender Male 167 (56)
Missing 1 (<1%)
Ethnicityb White 128 (43)
Black and minority ethnic 97 (33)
Missing 72 (24)
Receiving benefits Yes 223 (75)
Missing 30 (10)
Living situation Alone 106 (36)
Lives with spouse/family 133 (45)
Non-family, group home or other 55 (19)
Missing 3 (1)
Employment Paid employment 29 (9)
Not working/other 261 (88)
Missing 7 (2)
Most recent SMI diagnosis Schizophrenia 170 (57)
Bipolar disorder 61 (21)
Otherc 65 (22)
Missing 1 (<1%)
Smoking status Smoker 157 (53)
Missing 9 (3)
Smokers given cessation advice Yes 104 (66)
Missing 19 (12)
Alcohol drinkers Yes 156 (53)
Missing 12 (4)
Recreational drug use Yes 48 (16)
Missing 15 (5)
Evidence of a dual diagnosis Yes 75 (25)
Missing 21 (7)
Entitled to Section 117 (Mental Health Act 1983) aftercare Yes 49 (16)
Missing 177 (60)
Subject to a community treatment order Yes 21 (7)
Missing 187 (63)
Most recent cluster Care cluster 11: ongoing/recurrent psychosis (low symptom) 122 (41)
Care cluster 12: ongoing/recurrent psychosis (high disability) 73 (25)
Care cluster 13: ongoing/recurrent psychosis (high symptom and disability) 40 (13)
Care clusters 14–17d 28 (9)
Number of types of medications takene n = 295
Median {IQR} 2 {1–3}
Types of medicationf Atypical antipsychotic 237 (80)
Antidepressant medication 107 (36)
Conventional antipsychotic 74 (25)
Bipolar disorder medication 72 (24)
Anti-anxiety medication 80 (27)
Other medication 64 (22)
Number of other physical health conditionsg n = 295
Median {IQR} 1 {0–2}
0 103 (35)
1 111 (37)
≥2 81 (27)

SMI, severe mental illness; IQR, interquartile range.

a.

The majority of these data were taken from the primary care pro forma. However, where there was no data for a particular variable on the primary care form and there was data in the secondary care form, the secondary care data was used, to minimise the amount of missing data.

b.

Ethnicity: there was a high level of missing data as this was only collected adequately in one site (Birmingham); however, the missing data is likely to represent a high proportion of White individuals.

c.

Other diagnoses included schizotypal personality disorder, persistent delusional disorder, acute/transient psychotic disorder, induced delusional disorder, schizoaffective disorder, severe depression with psychosis and other.

d.

Care cluster 14–17: 14 (psychotic crisis), 15 (severe psychotic depression), 16 (dual diagnosis – substance misuse and mental illness) and 17 (psychosis and affective disorder – difficult to engage). Care clusters provide a framework for planning and organising mental health services, care and support that can be provided for individuals linked to the payment-by-results model.

e.

Types of medication include conventional antipsychotics, atypical antipsychotics, bipolar disorder medications, antidepressant medications, antianxiety medications, other mental health medications and any other medication.

f.

People can receive more than one type of medication, therefore percentages can add up to more than 100%. Bipolar disorder medications included (see Supplementary File 1) carbamazepine, gabapentin, lamotrigine, lithium carbonate, lithium citrate, valproic acid and topimarate.

g.

Physical conditions include diabetes, asthma, chronic obstructive pulmonary disorder, epilepsy, hypertension, stroke, thyroid disorder, ischaemic heart disease, heart failure, chronic kidney disease, learning disability, hearing problems, rheumatoid arthritis, cancer, osteoarthritis, obesity, visual problems and other.